For decades RSV was thought of as a childhood illness. We now know that it is a major driver of winter hospital admissions in older adults as well. People aged 60 and over, and especially those with heart, lung or kidney conditions, are at meaningfully higher risk of severe RSV than younger people.
Why a separate vaccine for older adults?
The maternal RSV vaccine used in pregnancy and the older-adult RSV vaccine are formulated differently. The older-adult vaccine produces a strong immune response in mature immune systems. It is given as a single dose.
Who is recommended to consider it
- Anyone aged 75 and over.
- Aboriginal and Torres Strait Islander adults aged 60 and over.
- Adults aged 60–74 with risk conditions, chronic lung disease, heart failure, chronic kidney disease, diabetes with end-organ damage, or who are immunocompromised.
Eligibility for NIP funding sits with ATAGI and is updated periodically. Your immuniser will confirm at the consult.
Timing
Ideally given in late summer or early autumn, so that protection is highest through winter, when RSV peaks in Australia. RSV vaccination can be given at the same visit as your flu shot, just in a different arm.
Side-effect profile
Mostly mild, soreness, fatigue, low-grade fever for a day. The 15-minute observation period applies. Talk to your immuniser about any past severe vaccine reaction or anaphylaxis history.
For pregnancy-specific RSV vaccination, see our companion article on RSV in pregnancy.
Sources & further reading
General information only. This article is educational and is not a substitute for personal medical advice. Your immuniser will confirm eligibility and contraindications on the day.
TGA advertising compliance. Vaccines are referred to by disease or category in line with the Therapeutic Goods Advertising Code. Specific brands and registered indications are discussed at the consultation.